The acting commissioner of the Food and Drug Administration has called for a government investigation into her own agency’s approval of Biogen’s new Alzheimer’s disease drug.

from MarketWatch.com - Top Stories https://ift.tt/3yDFQ3F
via IFTTT
from MarketWatch.com - Top Stories https://ift.tt/3yDFQ3F
via IFTTT
Kommentare
Kommentar veröffentlichen